Remove Medical science Remove Physicians Remove Side effects
article thumbnail

What Physicians Want from Pharma—And Where—During Diagnosis and Treatment

PM360

For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions.

article thumbnail

Progressing personalised cell therapies in oncology

European Pharmaceutical Review

It will also be important for referring physicians like myself, to begin thinking about referrals earlier than they may have traditionally done so in the past. About the interviewee Imran Khan, MD, PhD is Vice President Medical Affairs, Hematology at Johnson & Johnson Innovative Medicine. Medical Affairs. Cancer.gov.

article thumbnail

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Medgadget

Currently, the awkwardness of conventional laparoscopic tools keeps many physicians from using them in a variety of cases. ” An attractive proposition in a world in which technology has contributed significantly to the distancing of physicians from their patients, usually leading to negative side effects.

article thumbnail

Currency of Information

PM360

Medical science Liaisons know that change is coming; How are they cashing in? Medical science liaisons (MSLs) within pharmaceutical companies deal in a special currency: scientific exchange and real-world insights gathering.